These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7454610)

  • 1. Biotransformation of a new hypoglycemic agent, N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) in humans and rats.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(1):37-46. PubMed ID: 7454610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of a new hypoglycemic agent SPC-703.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(2):165-72. PubMed ID: 7454622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of glibornuride in the human].
    Bigler F; Quitt P; Vecchi M; Vetter W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2191. PubMed ID: 4679249
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of some salicylates and sulfonamides on binding by albumin of SPC-703 and tolbutamide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1976; 28(2):129-35. PubMed ID: 945561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of sulfonylurea derivatives to bovine serum albumin: part II. The relationship of binding to albumin, chemical structure, and hypoglycemic activity of sulfonamide derivatives of 2-pyrazoline-1-carboxamide.
    Wójcikowski C; Brzozowski Z; Chorosiński A
    Pol J Pharmacol Pharm; 1977; 29(5):477-83. PubMed ID: 593965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of the metabolites of a new hypoglycaemic agent, midaglizole, in dogs.
    Nakaoka M; Hakusui H
    Xenobiotica; 1987 Nov; 17(11):1329-39. PubMed ID: 3433802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of 2-para-methoxybenzenesulfonamido-5-isobutyl-1,3,4-thiadiazole, a hypoglycemia agent in rats and dogs.
    Ruelius HW; De Jongh DC; Shrader SR
    Arzneimittelforschung; 1970 Jan; 20(1):115-20. PubMed ID: 5467434
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats.
    Yamazaki H; Tabata S
    Arzneimittelforschung; 1993 Dec; 43(12):1317-21. PubMed ID: 8141820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and structure determination of the metabolites of 2-(1,3-dimethyl-xanthinyl-(7)-methyl)-4-methyl-morpholine--a xantinol derivative--from rat urine (author's transl)].
    Tauscher M; Eckhardt G; Geisel B; Schroeder G
    Arzneimittelforschung; 1977; 27(12):2344-7. PubMed ID: 580049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New compounds and reactions of sulfonamides with amines. XII. Synthesis of some derivatives of N-(benzenesulfonyl)-delta 2-pyrazoline-1-carboxamide].
    Brzozowski Z
    Acta Pol Pharm; 1974; 31(3):293-9. PubMed ID: 4849239
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of glibornuride].
    Rentsch G; Schmidt HA; Rieder J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic study in the rat of a new hypoglycemic agent: glisolamide].
    Cerri L; Dalla Vedova R; Groppetti A
    G Clin Med; 1979 Nov; 60(11):903-10. PubMed ID: 546671
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.
    Fuccella LM; Tamassia V; Valzelli G
    J Clin Pharmacol New Drugs; 1973; 13(2):68-75. PubMed ID: 4631138
    [No Abstract]   [Full Text] [Related]  

  • 16. [New compounds and reactions of sulfonamides with amines. XIV. Hypoglycemic properties of some derivatives of N-(benzenosulfonyl)-delta-2-pyrazoline-1-carboxamide].
    Brzozowski Z; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1974; 31(5):601-6. PubMed ID: 4447012
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
    Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biotransformation und pharmacokinetics of beta-methyl[1,1'-biphenyl]-4-propanenitrile (LU 20884) in rats. Studies on biotransformation].
    Neidlein R; Hofmann G
    Arzneimittelforschung; 1983; 33(7):920-5. PubMed ID: 6605150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral therapeutic system delivering a water insoluble drug: N-(4-[2-(3-methylpyrazole-1-carbonamide)ethyl]-benzenesulfonyl)N - cyclohexylurea (SPC-5002).
    Janicki S; Jedras Z; Sawicki W
    Acta Pharm Hung; 1988 Jul; 58(4):145-51. PubMed ID: 3223284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.